AARP Responds to First 10 Medicare Part D Drugs Selected for Historic Negotiation En español | WASHINGTON— AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ list of the first 10 drugs to be negotiated for lower prices by Medicare: […]
Survey Finds Older Adults Have an Optimistic Outlook on Life; Expect Their Lives to Improve as They Get Older WASHINGTON—According …
Medicare will now negotiate drug prices every year, thanks to the 2022 prescription drug law that AARP championed, benefitting millions …
WASHINGTON—AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees Reports released …
WASHINGTON—Today, AARP CEO Jo Ann Jenkins issued the following statement in response to President Biden’s State of the Union address: …
WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today following the House …
AARP Statement on New CMS Proposal to Require Minimum Nursing Home Staffing Levels WASHINGTON— AARP Executive Vice President and Chief …
